Factor V Leiden thrombophilia (Q34152374)

31 July 2017

1 reference

title

Factor V Leiden thrombophilia (English)

1 reference

31 July 2017

1 reference

1 reference

Jody Lynn Kujovich

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2011

1 reference

full work available at URL

31 July 2017

http://www.gimjournal.org/article/S1098360021040430/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21116184

https://api.elsevier.com/content/article/PII:S1098360021040430?httpAccept=text/xml

4 September 2024

1 reference

10.1097/GIM.0B013E3181FAA0F2

DOI

https://api.crossref.org/works/10.1097/GIM.0B013E3181FAA0F2

https://api.elsevier.com/content/article/PII:S1098360021040430?httpAccept=text/plain

4 September 2024

1 reference

10.1097/GIM.0B013E3181FAA0F2

DOI

https://api.crossref.org/works/10.1097/GIM.0B013E3181FAA0F2

4 September 2024

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

1-16

1 reference

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Mutation in blood coagulation factor V associated with resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Advances in understanding pathogenic mechanisms of thrombophilic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

World distribution of factor V Leiden

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

American College of Medical Genetics consensus statement on factor V Leiden mutation testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Clinical guidelines for testing for heritable thrombophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Hyperhomocysteinemia in cerebral vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

An unfavorable combination of Factor V Leiden with age, weight, and blood group causes high risk of pregnancy-associated venous thrombosis: a population-based nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Increased frequency of genetic thrombophilia in women with complications of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Genetics of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Factor V Leiden and recurrent miscarriage-prospective outcome of untreated pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Thrombophilic disorders and fetal loss: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Factor V Leiden and the risk for venous thromboembolism in the adult Danish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Thrombophilia, clinical factors, and recurrent venous thrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Mutations in coagulation factors in women with unexplained late fetal loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Factor V Leiden as risk factor for unexplained stillbirth--a population-based nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Inherited thrombophilia and pregnancy complications revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Maternal thrombophilia and the risk of recurrence of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Absence of association of thrombophilia polymorphisms with intrauterine growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Estrogen plus progestin and risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Long term use of oral contraceptives without thrombosis in patients with FV Leiden polymorphism: a study of 37 patients (2 homozygous and 35 heterozygous).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

A single-centre prospective study of clinical and haemostatic risk factors for venous thromboembolism following lower limb arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Relation of Factor V Leiden Genotype to Risk for Acute Deep Venous Thrombosis after Joint Replacement Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Fine particulate: it matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Thrombophilic risk factors in patients with severe carotid atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

An underestimated combination of opposites resulting in enhanced thrombotic tendency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Two novel factor V null mutations associated with activated protein C resistance phenotype/genotype discrepancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Prevalence of factor V leiden, factor V cambridge, factor II G20210A and methylenetetrahydrofolate reductase C677T mutations in healthy and thrombophilic Serbian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

The Incidence of Venous Thromboembolism in Family Members of Patients with Factor V Leiden Mutation and Venous Thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

Risk of recurrence after a first venous thromboembolic event in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181FAA0F2

10.1097/GIM.0B013E3181FAA0F2

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1006598633

0 references

1 reference